SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-16-098297
Filing Date
2016-05-02
Accepted
2016-05-02 16:21:48
Documents
76
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v437137_10q.htm 10-Q 497570
2 EXHIBIT 31.1 v437137_ex31-1.htm EX-31.1 9455
3 EXHIBIT 31.2 v437137_ex31-2.htm EX-31.2 9269
4 EXHIBIT 32.1 v437137_ex32-1.htm EX-32.1 5208
  Complete submission text file 0001144204-16-098297.txt   5253281

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT acur-20160331.xml EX-101.INS 1225256
6 XBRL TAXONOMY EXTENSION SCHEMA acur-20160331.xsd EX-101.SCH 60073
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acur-20160331_cal.xml EX-101.CAL 46528
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acur-20160331_def.xml EX-101.DEF 329337
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE acur-20160331_lab.xml EX-101.LAB 414502
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acur-20160331_pre.xml EX-101.PRE 379478
Mailing Address 616 N. NORTH COURT, SUITE 120 . PALATINE IL 60067
Business Address 616 N. NORTH COURT, SUITE 120 PALATINE IL 60067 847-705-7709
ACURA PHARMACEUTICALS, INC (Filer) CIK: 0000786947 (see all company filings)

IRS No.: 110853640 | State of Incorp.: NY | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10113 | Film No.: 161611909
SIC: 2834 Pharmaceutical Preparations